Dose Cancer Research Results

Dose, Dosage: Click to Expand ⟱
Source:
Type:
Drug dosage vs efficacy, and actual dosage number of research papers.


Scientific Papers found: Click to Expand⟱
2001- Ash,    Withania somnifera: from prevention to treatment of cancer
- Review, Var, NA
toxicity↓, TumW↓, Dose?, eff↝, Ki-67↓, survivin↓, XIAP↓, PERK↑, p‑RSK↑, CHOP/DDIT3↑, DR5↑, Dose↝, BG↓, DNMTs↓,
8806- Ash,    Systematic review and network meta-analysis of the effects of plant active substance on quality of life in breast cancer patients
- Review, BC, NA
Dose?, QoL↑, fatigue↓, Pain↓, Nausea↓, chemoP↑,
2612- Ba,  MF,    The effect of a static magnetic field and baicalin or baicalein interactions on amelanotic melanoma cell cultures (C32)
- in-vitro, Melanoma, NA
SOD1↑, SOD2↑, GPx1↑, Dose?, eff↝, SOD1↓, SOD2↓, GPx1↓,
2686- BBR,    Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
- Review, Nor, NA
Inflam↓, IL6↓, MCP1/CCL2↓, COX2/PTGS2↓, PGE2↓, MMP2↓, MMP9↓, DNAdam↑, eff↝, Telomerase↓, Bcl-2↓, AMPK↑, ROS↑, MMP↓, ATP↓, p‑mTORC1↓, p‑S6K↓, ERK↓, PI3K↓, PTEN↑, Akt↓, Raf↓, MEK↓, Dose↓, Dose↑, selectivity↑, TumCCA↑, Synergy↑, EGFR↓, Glycolysis↓, Dose?, p27/CDKN1B↑, CDK2↓, CDK4↓, cycD1/CCND1↓, cycE/CCNE↓, Bax:Bcl2↑, Casp3↑, Casp9↑, VEGFR2/KDR/Flk1↓, ChemoSen↑, Synergy↑, Synergy↑, PGE2↓, JAK2↓, STAT3↓, CXCR4↓, CCR7↓, uPA↓, CSCs↓, EMT↓, Diff↓, CD133↓, Nestin↓, n-MYC↓, NOTCH↓, SOX2↓, Hif1a↓, VEGF↓, RadioS↑,
1650- CA,    Adjuvant Properties of Caffeic Acid in Cancer Treatment
- Review, Var, NA
ROS↑, antiOx↑, Inflam↓, AntiCan↑, NF-kB↓, STAT3↓, ERK↓, ChemoSen↑, RadioS↑, AMPK↑, eff↑, selectivity↑, COX2/PTGS2↓, Dose∅, PHDs↓, MMP9↓, MMP2↓, Dose∅, Dose∅, Ca+2↑, Dose?, MMP↓, RadioS↑,
1518- CAP,    Capsaicin-mediated tNOX (ENOX2) up-regulation enhances cell proliferation and migration in vitro and in vivo
- in-vitro, CRC, HCT116
ENOX2↑, TumCP↑, TumCMig↑, Dose?, eff↑,
9142- CC,  immuno,    Combination nivolumab and ipilimumab with and without camu camu in first-line treatment of metastatic renal cell carcinoma (mRCC)
- Trial, RCC, NA
GutMicro↑, CD8+↑, CD4+↑, Synergy?, Dose?,
9134- CC,    Camu camu plus nivolumab/ipilimumab (N/I) as first-line therapy for metastatic renal cell carcinoma (mRCC): A randomized phase I trial
- Trial, RCC, NA
Dose?, GutMicro↑, toxicity↝, PFS↑,
1586- Citrate,    Extracellular Citrate Is a Trojan Horse for Cancer Cells
- in-vitro, Liver, HepG2
Dose?, ac‑H4↓, lipidDe↓, ACLY↓, selectivity↑, *ACLY∅, Glycolysis↓, NADH↓, OAA↑, other↑,
1578- Citrate,    Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update
- Review, Var, NA
TCA↑, FASN↑, Glycolysis↓, glucoNG↑, PFK1↓, PFK2↓, FBPase↑, TumCP↓, eff↑, ACLY↓, Dose↑, Casp3↑, Casp2↑, Casp8↑, Casp9↑, Bcl-xL↓, Mcl-1↓, IGF-1R↓, PI3K↓, Akt↓, mTOR↓, PTEN↑, ChemoSen↑, Dose?,
4769- CoQ10,    CoQ10 Is Key for Cellular Energy and Cancer Support
- Review, Var, NA
Risk↓, TumCG↓, angioG↓, TumCD↑, *toxicity↓, *BioAv↑, MMPs↓, Inflam↓, chemoP↑, cardioP↑, *ROS↓, *toxicity↝, Dose?,
5808- CPT,    Repair of Topoisomerase I-Mediated DNA Damage
- Review, Var, NA
TOP1↓, AntiCan↑, Dose?, CHK1↑, Chk2↑,
1616- CUR,  EA,    Kinetics of Inhibition of Monoamine Oxidase Using Curcumin and Ellagic Acid
- in-vitro, Nor, NA
*MAOA↓, *Dose∅, Dose?,
8830- DIM,  Tam,    A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen
- Trial, BC, NA
Dose?, 2/16-OHE1↓, SHBG↑,
8832- DIM,    Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy
- Trial, Pca, NA
Dose?, *toxicity↓, BioAv↑, 2/16-OHE1↝, eff↝,
6270- DL,    d-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer
- vitro+vivo, Lung, A549 - vitro+vivo, Lung, H1299
TumCG↓, Apoptosis↑, TumAuto↑, Dose?,
6366- DRE,    A comprehensive review of the benefits of Taraxacum officinale on human health
- Review, Var, NA
*diuretic↑, *hepatoP↑, *Imm↑, *Bacteria↓, *AntiArt↑, *AntiDiabetic↑, *Obesity↓, *antiOx↓, *AntiCan↑, Dose?,
6604- Ech,    Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion
- Human, Nor, NA
*BioAv↑, *Half-Life↝, *Dose↝, Dose?,
6618- Ech,    Kaempferols from Echinacea purpurea demonstrate anti-cancer potential by targeting anexelekto in breast cancer therapy using chemoinformatics approach
- Analysis, BC, NA
AXL↓, Dose?,
1514- EGCG,    Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture
- in-vitro, Cerv, HeLa - in-vitro, Nor, MCF10
selectivity↑, *toxicity∅, TumCG↓, NADHdeh?, eff↑, ENOX2↓, Dose?,
2144- Ex,    Physical activity, hormone replacement therapy and breast cancer risk: A meta-analysis of prospective studies
- Analysis, BC, NA
Risk↓, Dose?, eff↑,
2497- FBZ,    In vitro anti-tubulin effects of mebendazole and fenbendazole on canine glioma cells
- in-vitro, GBM, NA
Dose?, selectivity↑, TumCD↑, α-tubulin↓,
8598- FSO,  Tras,    Flaxseed oil-trastuzumab interaction in breast cancer
- in-vivo, BC, NA
Dose?, Synergy↑,
1954- GamB,    Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase
- in-vitro, HCC, SMMC-7721 cell
AntiTum↑, TrxR↓, TrxR1↓, ROS↑, Apoptosis↑, Dose∅, Dose?,
7138- GI,    6-Shogaol exerts anti-proliferative and pro-apoptotic effects through the modulation of STAT3 and MAPKs signaling pathways
- vitro+vivo, BC, MDA-MB-231 - in-vitro, Pca, DU145 - in-vitro, Liver, HepG2 - in-vitro, Lung, A549
TumCP↓, TumMeta↓, p‑STAT3↓, JAK2↓, cSrc↓, JNK↑, p38↑, ERK↑, eff↓, ROS↑, cl‑PARP↑, TumCCA↑, Casp8↑, Casp9↑, Casp3↑, eff↑, Bcl-2↑, Bcl-xL↓, survivin↓, MMP9↓, COX2/PTGS2↓, IAP1↓, Dose?,
1644- HCAs,  PBG,    Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid) sensitizes LNCaP prostate cancer cells to TRAIL-induced apoptosis
- in-vitro, Pca, LNCaP
NF-kB↓, TRAILR↑, Casp8↑, Casp3↑, MMP↓, Dose?,
9180- ITCs,  SFN,    Epigenetics/epigenomics and prevention of early stages of cancer by isothiocyanates Review
- Review, Var, NA
HDAC↓, DNMT1↓, DNMT3B↓, BioAv↑, chemoPv↑, NRF2↑, HO-1↑, NQO1↑, GSK‐3β↓, β-catenin/ZEB1↓, EMT↓, ac‑H3↑, ac‑H4↑, Wnt↓, HDAC3↓, p‑γH2AX↑, hTERT/TERT↓, NA↑, cMyc↓, HDAC2↓, HDAC3↓, KLF4↓, TumVol↓, Dose?,
8064- KAE,    Kaempferol Inhibits Pancreatic Cancer Cell Growth and Migration through the Blockade of EGFR-Related Pathway In Vitro
- in-vitro, PC, MIA PaCa-2 - in-vitro, PC, PANC1 - in-vitro, PC, SNU-213
AntiCan↑, tumCV↓, Apoptosis↑, TumCMig↓, *toxicity↓, Dose?,
9006- L-THE,    Theanine from tea and its semi-synthetic derivative TBrC suppress human cervical cancer growth and migration by inhibiting EGFR/Met-Akt/NF-κB signaling
- vitro+vivo, Cerv, HeLa
TumCG↓, TumCMig↓, EZH2↓, TumCG↓, toxicity↓, Dose?, TumVol↓,
8270- LE,  Rad,    Comparative Study of the Effect of Licorice Muco-adhesive Film on Radiotherapy Induced Oral Mucositis, A Randomized Controlled Clinical Trial
- Trial, HNSCC, NA
Dose?, Pain↓, Mucositis↓,
8125- LF,    Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)
- Trial, NSCLC, NA
Dose?, eff∅,
1534- LT,  Api,  EGCG,  RES,    Plant polyphenol induced cell death in human cancer cells involves mobilization of intracellular copper ions and reactive oxygen species generation: a mechanism for cancer chemopreventive action
- in-vitro, Nor, MCF10 - in-vitro, BC, MDA-MB-231 - in-vitro, BC, MDA-MB-468 - in-vitro, PC, Bxpc-3
TumCP↓, Apoptosis↑, eff↓, *toxicity↑, Dose?, eff↓, eff↓,
8732- M-Blu,    Methylene blue for intractable pain from oral mucositis related to cancer treatment: a randomized phase 2 clinical trial
- Trial, Var, NA
Dose?, Mucositis↓, Pain↓,
8572- Matr,    Matrine induces mitochondrial apoptosis in cisplatin-resistant non-small cell lung cancer cells via suppression of β-catenin/survivin signaling
- in-vitro, Lung, A549 - in-vitro, Lung, H460
Dose?, β-catenin/ZEB1↓, survivin↓, MMP↓, Casp9↑, Casp3↑,
8631- MBZ,  BEV,    Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer
- Trial, CRC, NA
Dose?, Synergy↑, PFS↑, VEGF↓, ChemoSen↑,
8479- MFrot,  doxoR,    Dual-targeting by rotating magnetic field-driven superparamagnetic bionic nanorobots for enhanced triple-negative breast cancer therapy
- vitro+vivo, BC, 4T1
Dose?, EPR↑, BioEnh↑, GSH↓, GPx4↓, Iron↑, ROS↑, lipid-P↑, Ferroptosis↑, TumVol↓, Fenton↑,
7388- MFrot,    Magnetoporation and magnetolysis of cancer cells via carbon nanotubes induced by rotating magnetic fields
- in-vitro, BC, MCF7
EPR↑, Dose?,
9074- MGF,    Mangiferin prevents the growth of gastric carcinoma by blocking the PI3K-Akt signalling pathway
- in-vitro, GC, SGC-7901 - in-vitro, GC, BGC-823
TumCP↓, Dose?, Bcl-2↓, Bcl-xL↓, Mcl-1↓, BAX↑, BAD?, cl‑Casp3↑, cl‑Casp9↑, p‑PI3K↓, p‑Akt↓, p‑mTOR↓, toxicity↓,
8659- MLT,  Cisplatin,    Melatonin Sensitizes OVCAR-3 Cells to Cisplatin through Suppression of PI3K/Akt Pathway
- in-vitro, Ovarian, OVCAR-3
Dose?, ROS↑, cl‑Casp3↑, p‑Akt↓, ChemoSen↑, Apoptosis↑, PI3K↓, Akt↓,
8692- MLT,    Melatonin as a Radio-Sensitizer in Cancer
- Review, Var, NA
RadioS↑, radioP↑, ROS↑, DNArepair↓, angioG↓, Inflam↓, Apoptosis↑, Telomerase↓, HSP70/HSPA5↑, P53↑, Glycolysis↓, Dose?, OS∅,
8691- MLT,    Melatonin effect on hypoxia inducible factor-1α and clinical response in patients with oral squamous cell carcinoma receiving neoadjuvant chemotherapy: A randomized controlled trial
- Trial, Oral, NA
Hif1a↓, Dose?, eff∅,
8918- MP,  Cisplatin,    Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling
- in-vitro, BC, T47D - in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-231 - in-vitro, BC, MDA-MB-231
Dose?, TumCP↓, DNAdam↑, TumCCA↑, PRL↓, JAK2↓, STAT5↓, cycD1/CCND1↓, ChemoSen↑,
8805- MT/VAE,  Chemo,    Mistletoe extract in patients with advanced pancreatic cancer: Health-related quality of life in a double-blind, randomized, placebo-controlled trial (MISTRAL)
- Trial, PC, NA
Dose?, QoL∅, Weight∅, CRP∅, ALB∅, Eos↑, eff∅, Synergy∅,
8936- MushCha,    Inonotus obliquus polysaccharides induces apoptosis of lung cancer cells and alters energy metabolism via the LKB1/AMPK axis
- vitro+vivo, Lung, LLC1
AMPK↑, tumCV↓, Apoptosis↑, Bcl-2↓, BAX↑, cl‑Casp3↑, cl‑PARP↑, MMP↓, OXPHOS↓, Glycolysis↓, Dose?, MPT↑, ATP↓,
8938- MushCha,    Bioactivity-based analysis and chemical characterization of cytotoxic constituents from Chaga mushroom (Inonotus obliquus) that induce apoptosis in human lung adenocarcinoma cells
- in-vitro, Lung, A549 - in-vitro, Lung, H1299 - in-vitro, Lung, Calu-6
Apoptosis↑, Casp3↑, Dose?,
9057- PatchO,    Essential Oil Compound, Patchouli Alcohol, Represses Tumor Formation in Vivo and Causes G1 Arrest by Downregulating β-catenin Transcriptional Activity in Colon Cancer Cells (FS13-02-19)
- vitro+vivo, CRC, HT-29 - vitro+vivo, Colon, Caco-2
*Inflam↓, *Obesity↓, *AntiCan↑, Dose?, TumNum↓, TumCCA↑, TumCP↓, Polyps↓, β-catenin/ZEB1↓,
1647- PBG,  CA,    Antioxidant Properties and Phenolic Composition of Greek Propolis Extracts
- Analysis, Nor, NA
Dose?, antiOx↑, other↑,
1660- PBG,    Emerging Adjuvant Therapy for Cancer: Propolis and its Constituents
- Review, Var, NA
MMPs↓, angioG↓, TumMeta↓, TumCCA↑, Apoptosis↑, ChemoSideEff↓, eff∅, HDAC↓, PTEN↑, p‑PTEN↓, p‑Akt↓, Casp3↑, p‑ERK↑, p‑FAK↑, Dose?, Akt↓, GSK‐3β↓, FOXO3↓, ChemoSen↑, IL2↑, IL10↑, NF-kB↓, VEGF↓, mtDam↑, ER Stress↑, AST↓, ALAT↓, ALP↓, COX2/PTGS2↓, eff↑, Bax:Bcl2↑,
1666- PBG,    Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against Cancer
- Review, Var, NA
ChemoSen↑, TumCCA↑, TumCP↓, Apoptosis↑, antiOx↓, ROS↑, COX2/PTGS2↑, ER(estro)↓, cycA1/CCNA1↓, CycB/CCNB1↓, CDK2↓, P21↑, p27/CDKN1B↑, hTERT/TERT↓, HDAC↓, ROS⇅, Dose?, ROS↓, ROS↑, DNAdam↑, ChemoSen↑, LOX1↓, lipid-P↓, NO↑, Igs↑, NK cell↑, MMPs↓, VEGF↓, Hif1a↓, GLUT1↓, HK2↓, selectivity↑, RadioS↑, GlucoseCon↓, lactateProd↓, eff↓, *BioAv↓,
1663- PBG,    Propolis and Their Active Constituents for Chronic Diseases
- Review, Var, NA
NF-kB↓, Casp↓, Fas↓, DNAdam↑, Casp3↑, P53↝, MMP↝, ROS↑, mtDam↑, Dose?, angioG↓, TumCP↓, TumCMig↓, BAX↑, selectivity↑, MMP↓, LDH↓, IL6↓, IL1β↓, TNF-α↓,

Showing Research Papers: 1 to 50 of 58
Page 1 of 2 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 58

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   antiOx↑, 2,   ENOX2↓, 1,   ENOX2↑, 1,   Fenton↑, 1,   GPx1↓, 1,   GPx1↑, 1,   GPx4↓, 1,   GSH↓, 1,   H2O2↑, 2,   HO-1↑, 1,   Iron↑, 1,   lipid-P↓, 1,   lipid-P↑, 1,   lipidDe↓, 1,   NADH↓, 1,   NADHdeh?, 1,   NQO1↑, 1,   NRF2↑, 1,   ROS↓, 1,   ROS↑, 13,   ROS⇅, 1,   SOD1↓, 1,   SOD1↑, 1,   SOD2↓, 1,   SOD2↑, 1,   TrxR↓, 1,   TrxR1↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

mtDam↑, 2,   OXPHOS↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ACLY↓, 2,   ALAT↓, 1,   AMPK↑, 3,   ATP↓, 2,   FASN↑, 1,   FBPase↑, 1,   glucoNG↑, 1,   GlucoseCon↓, 1,   Glycolysis↓, 5,   GSK‐3β↓, 2,   HK2↓, 1,   lactateProd↓, 1,   OAA↑, 1,   PFK1↓, 1,   PFK2↓, 1,   TCA↑, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↑, 12,   BAD?, 1,   BAX↑, 3,   Bax:Bcl2↑, 2,   Bcl-2↓, 3,   Bcl-2↑, 1,   Bcl-xL↓, 3,   Casp↓, 1,   Casp2↑, 1,   Casp3↑, 9,   cl‑Casp3↑, 3,   Casp8↑, 3,   Casp9↑, 4,   cl‑Casp9↑, 1,   DR5↑, 1,   Fas↓, 1,   Ferroptosis↑, 1,   IAP1↓, 1,   Mcl-1↓, 2,   p38↑, 1,   survivin↓, 3,   TRAILR↑, 1,   TumCD↑, 3,   XIAP↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 4,   p‑Akt↓, 3,   cSrc↓, 1,   EGFR↓, 1,   ERK↓, 2,   ERK↑, 1,   p‑ERK↑, 1,   IGF-1R↓, 1,   JAK2↓, 3,   JNK↑, 1,   MEK↓, 1,   mTOR↓, 1,   p‑mTOR↓, 1,   PI3K↓, 3,   p‑PI3K↓, 1,   PTEN↑, 3,   p‑PTEN↓, 1,   Raf↓, 1,   p‑RSK↑, 1,   p‑S6K↓, 1,   STAT3↓, 2,   p‑STAT3↓, 1,   STAT5↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

cJun↑, 1,   cMyc↓, 1,   DNMT1↓, 1,   DNMT3B↓, 1,   DNMTs↓, 1,   EZH2↓, 1,   FOXO3↓, 1,   ac‑H3↑, 1,   ac‑H4↓, 1,   ac‑H4↑, 1,   HDAC↓, 3,   HDAC2↓, 1,   HDAC3↓, 2,   KLF4↓, 1,   n-MYC↓, 1,   other↓, 2,   other↑, 2,   SOX2↓, 1,   tumCV↓, 2,   UrinaryC↑, 1,   Wmax↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 1,   ER Stress↑, 1,   HSP70/HSPA5↑, 1,   PERK↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

TumAuto↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↑, 6,   DNArepair↓, 1,   hTERT/TERT↓, 2,   P53↑, 2,   P53↝, 1,   cl‑PARP↑, 2,   Telomerase↓, 2,   TOP1↓, 1,   p‑γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK2↓, 2,   CDK4↓, 1,   CHK1↑, 1,   Chk2↑, 1,   cycA1/CCNA1↓, 1,   CycB/CCNB1↓, 1,   cycD1/CCND1↓, 2,   cycE/CCNE↓, 1,   Ki-67↓, 2,   P21↑, 1,   p27/CDKN1B↑, 2,   TumCCA↑, 6,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

CD133↓, 1,   CSCs↓, 1,   Diff↓, 1,   Ki-67↓, 2,   p‑mTORC1↓, 1,   Nestin↓, 1,   NOTCH↓, 1,   TumCG↓, 5,   TumCP↓, 10,   TumCP↑, 1,   Wnt↓, 1,  

Migration(tgid=13) ⓘ

AXL↓, 1,   Ca+2↑, 1,   EMT↓, 2,   p‑FAK↑, 1,   MMP2↓, 2,   MMP9↓, 3,   MMPs↓, 3,   TumCA↓, 1,   TumCMig↓, 4,   TumCMig↑, 1,   TumMeta↓, 2,   uPA↓, 1,   α-tubulin↓, 1,   β-catenin/ZEB1↓, 3,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 5,   Hif1a↓, 3,   LOX1↓, 1,   NO↑, 1,   PHDs↓, 1,   VEGF↓, 4,   VEGFR2/KDR/Flk1↓, 1,  

Barriers & Transport(tgid=15) ⓘ

EPR↑, 2,   GLUT1↓, 1,   MMP↓, 7,   MMP↝, 1,   MPT↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCR7↓, 1,   CD4+↑, 1,   CD8+↑, 1,   COX2/PTGS2↓, 4,   COX2/PTGS2↑, 1,   CXCR4↓, 1,   Eos↑, 1,   Igs↑, 1,   IL10↑, 1,   IL1β↓, 1,   IL2↑, 1,   IL6↓, 2,   Inflam↓, 4,   MCP1/CCL2↓, 1,   NF-kB↓, 4,   NF-kB↑, 1,   NK cell↑, 1,   PGE2↓, 2,   PSA↓, 1,   TNF-α↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

2/16-OHE1↓, 1,   2/16-OHE1↝, 1,   ER(estro)↓, 1,   PRL↓, 1,   SHBG↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↑, 2,   BioEnh↑, 1,   ChemoSen↑, 9,   Dose?, 58,   Dose↓, 1,   Dose↑, 2,   Dose↝, 1,   Dose∅, 4,   eff↓, 5,   eff↑, 9,   eff↝, 4,   eff∅, 4,   RadioS↑, 6,   selectivity↑, 8,   Synergy?, 1,   Synergy↑, 6,   Synergy∅, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 1,   ALB∅, 1,   ALP↓, 1,   AST↓, 1,   BG↓, 1,   CRP∅, 1,   EGFR↓, 1,   EZH2↓, 1,   hTERT/TERT↓, 2,   IL6↓, 2,   LDH↓, 1,   Polyps↓, 1,   PSA↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 3,   antiNeop↑, 1,   AntiTum↑, 1,   ANXi↓, 1,   cardioP↑, 1,   chemoP↑, 2,   chemoPv↑, 1,   ChemoSideEff↓, 1,   cognitive∅, 1,   fatigue↓, 1,   Mucositis↓, 2,   Nausea↓, 1,   OS∅, 1,   Pain↓, 3,   PFS↑, 2,   QoL↑, 1,   QoL∅, 1,   radioP↑, 1,   Risk↓, 2,   Stress↓, 1,   toxicity↓, 3,   toxicity↝, 1,   TumNum↓, 1,   TumVol↓, 3,   TumW↓, 1,   Weight∅, 1,  

Infection & Microbiome(tgid=24) ⓘ

GutMicro↑, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 2,  
Total Targets: 261

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   ROS↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ACLY∅, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

Imm↑, 1,   Inflam↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

MAOA↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 1,   BioAv↑, 2,   Dose↝, 1,   Dose∅, 1,   Half-Life↝, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiArt↑, 1,   AntiCan↑, 2,   AntiDiabetic↑, 1,   diuretic↑, 1,   hepatoP↑, 1,   Obesity↓, 2,   toxicity↓, 3,   toxicity↑, 1,   toxicity↝, 1,   toxicity∅, 1,  

Infection & Microbiome(tgid=24) ⓘ

Bacteria↓, 1,  
Total Targets: 22

Scientific Paper Hit Count for: Dose, Dosage
5 Propolis -bee glue
3 Melatonin
2 Ashwagandha(Withaferin A)
2 Caffeic acid
2 Camu camu
2 Citric Acid
2 Diindolylmethane
2 Echinacea
2 EGCG (Epigallocatechin Gallate)
2 Magnetic Field Rotating
2 Cisplatin
2 Mushroom Chaga, Inonotus obliquus
2 Vitamin C (Ascorbic Acid)
2 VitK3,menadione
1 Baicalein
1 Magnetic Fields
1 Berberine
1 Capsaicin
1 immunotherapy
1 Coenzyme Q10
1 Camptothecin
1 Curcumin
1 Ellagic acid
1 tamoxifen
1 D-limonene
1 Dandelion Root
1 Exercise
1 Fenbendazole
1 Flaxseed Oil
1 Trastuzumab
1 Gambogic Acid
1 Ginger/6-Shogaol/Gingerol
1 Hydroxycinnamic-acid
1 Isothiocyanates
1 Sulforaphane (mainly Broccoli)
1 Kaempferol
1 L-Theanine
1 Licorice
1 Radiotherapy/Radiation
1 Lactoferrin/Talactoferrin
1 Luteolin
1 Apigenin (mainly Parsley)
1 Resveratrol
1 Methylene blue
1 Matrine
1 mebendazole
1 Bevacizumab (brand Avastin)
1 doxorubicin
1 Mangiferin
1 Mucuna pruriens/Velvet Bean
1 Mistletoe/Viscum album Extracts
1 Chemotherapy
1 Patchouli Oil (Pogostemon cablin)
1 Phycocyanin
1 Pomi-T
1 SonoDynamic Therapy UltraSound
1 Spirulina(Arthrospira/Limnospira)
1 Whole Body Vibration
1 Walnut
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:0  prod#:%  Target#:1114  State#:%  Dir#:0
wNotes=0 sortOrder:rid,rpid

 

Home Page